The Bihar School Examination Board (BSEB) has come up with the Bihar Board Class 12 Exam Routine 2026. According to the BSEB ...

With the CBSE Board Exams 2026 fast approaching, it has become essential for students to understand what examiners actually look for in answer sheets. Using correct scientific terminology, following ...

INVITATION TO APPLY FOR THE POSITION OF NATIONAL SELECTOR OF THE BCCI Candidates who wish to apply for the stated positions ...

AstraZeneca's Dr. Sophie Kirschner to present data demonstrating how biomodal's 6--base sequencing solution enhances the sensitivity of liquid biopsy ...

NEOK Bio, Inc., an oncology therapeutics company focused on the development of novel antibody drug conjugates (ADCs) for improving outcomes for cancer patients, announced that the U.S. Food and Drug ...

President Trump appeared to scoop his own agency experts on Thursday night, posting new employment data hours before the Bureau of Labor Statistics released its latest jobs report. The president took ...

When making a Dungeons and Dragons character, few decisions are as important as the class. Furthermore, players must consider what level the campaign is reaching, as any given class is going to ...

New Married to Medicine friend Angel Love Davis may have been introduced as Miss Quad Webb's bestie, but she's way more than just a sidekick. Angel is "a successful registered nurse, entrepreneur, and ...

Oracle Corp., the Austin-based tech giant, is facing a potential class-action lawsuit over multiple data breaches this year impacting millions of people. A federal judge in Austin is currently ...

Alphabet Inc. has agreed to buy clean energy developer Intersect Power LLC for $4.75 billion in cash, plus existing debt, marking one of the largest deals by the tech giant to dramatically expand its ...

Alphabet announced an plan to buy Intersect for $4.75 billion to secure power for US data centers. The move comes as tech firms face rising grid constraints and AI infrastructure project delays.

CHICAGO, Dec. 18, 2025 /PRNewswire/ -- Amphix Bio today announced the initial closing of a $12.5 million seed financing round to advance its lead therapeutic candidates toward human clinical trials ...